100 Mg Acotiamide Tablets Market, Global Outlook and Forecast 2025-2032

Page 1


• Global 100 Mg Acotiamide Tablets market size was valued at USD 606 million in 2024. The market is projected to grow from USD 630 million in 2025 to USD 850 million by 2032, exhibiting a CAGR of 4.0% during the forecast period.

Email:

• Acotiamideisagastrointestinalmotilityenhancerusedprimarilyfortreatingfunctional dyspepsia and gastroparesis. The 100 mg dosage form represents a standardized therapeutic option that improves gastric emptying and reduces symptoms like postprandial fullness, early satiety, and upper abdominal bloating. Its mechanism involves acetylcholinesterase inhibition, which enhances acetylcholine-mediated gastrointestinalmotility.

Email:

blister packs

• Functional Dyspepsia • Gastroparesis • GERD (Gastroesophageal Reflux Disease)

• Others

Key Players :

•Sun Pharmaceutical Industries Ltd. (India)

•Steris Healthcare (India)

•Arlak Biotech (India)

•Logos Pharma (India)

•AKUMS (India)

•Care Formulation Labs (India)

•Cista Medicorp (India)

Email: help@intelmarketresearch.com +91 9169164321

Turn static files into dynamic content formats.

Create a flipbook
Issuu converts static files into: digital portfolios, online yearbooks, online catalogs, digital photo albums and more. Sign up and create your flipbook.